TY - JOUR
T1 - Pathogenic NF1 truncating mutation and copy number alterations in a dedifferentiated liposarcoma with multiple lung metastasis
T2 - A case report
AU - Kim, Yoon Seob
AU - Shin, Sun
AU - Jung, Seung Hyun
AU - Chung, Yeun Jun
N1 - Publisher Copyright:
© 2020 The Author(s).
PY - 2020/10/12
Y1 - 2020/10/12
N2 - Background: Dedifferentiated liposarcoma (DDLPS), which accounts for an estimated 15-20% of liposarcomas, is a high-grade and aggressive malignant neoplasm, exhibiting a poor response to available therapeutic agents. However, genetic alteration profiles of DDLPS as well as the role of NF1 mutations have not been studied extensively. Case presentation: The current study reports a patient presenting with rapidly growing DDLPS accompanied by multiple lung and pleural metastases, in whom whole-exome sequencing revealed a NF1 truncating mutation of the known pathogenic variant, c.C7486T, p.R2496X, as well as multiple copy number alterations (CNAs), including the well-known 12q13-15 amplification, and multiple chromothripsis events encompassing potential cancer-related genes. Conclusions: Our results suggest that, in addition to the 12q13-15 amplification, NF1 inactivation mutation and other CNAs may contribute to DDLPS tumorigenesis accompanied by aggressive clinical features.
AB - Background: Dedifferentiated liposarcoma (DDLPS), which accounts for an estimated 15-20% of liposarcomas, is a high-grade and aggressive malignant neoplasm, exhibiting a poor response to available therapeutic agents. However, genetic alteration profiles of DDLPS as well as the role of NF1 mutations have not been studied extensively. Case presentation: The current study reports a patient presenting with rapidly growing DDLPS accompanied by multiple lung and pleural metastases, in whom whole-exome sequencing revealed a NF1 truncating mutation of the known pathogenic variant, c.C7486T, p.R2496X, as well as multiple copy number alterations (CNAs), including the well-known 12q13-15 amplification, and multiple chromothripsis events encompassing potential cancer-related genes. Conclusions: Our results suggest that, in addition to the 12q13-15 amplification, NF1 inactivation mutation and other CNAs may contribute to DDLPS tumorigenesis accompanied by aggressive clinical features.
KW - Case report
KW - Copy number alteration
KW - Copy number alternation
KW - Liposarcoma
KW - Mutation
KW - NF1
UR - https://www.scopus.com/pages/publications/85092584739
U2 - 10.1186/s12881-020-01137-4
DO - 10.1186/s12881-020-01137-4
M3 - Article
C2 - 33046013
AN - SCOPUS:85092584739
SN - 1471-2350
VL - 21
JO - BMC Medical Genetics
JF - BMC Medical Genetics
IS - 1
M1 - 200
ER -